Sionna Therapeutics (SION) Research & Development (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Research & Development data on file, last reported at $19.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 38.74% year-over-year to $19.0 million; the trailing twelve-month figure through Mar 2026 stood at $65.6 million (up 7.94% YoY), and the FY2025 full-year result was $60.3 million, up 5.19% from the prior year.
• Research & Development improved to $19.0 million in Q1 2026, from $15.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $24.6 million in Q3 2024 to a low of $8.2 million in Q2 2024.
• A 3-year average of $15.2 million and a median of $15.2 million in 2025 frame the typical range for Research & Development.
• Peak annual rise in Research & Development reached 86.85% in 2025, while the deepest fall reached 34.73% in 2025.
• Tracing SION's Research & Development over 3 years: stood at $14.3 million in 2024, then rose by 6.42% to $15.2 million in 2025, then advanced by 25.02% to $19.0 million in 2026.
• Business Quant data shows SION's Research & Development at $19.0 million in Q1 2026, $15.2 million in Q4 2025, and $16.0 million in Q3 2025.